Business / Finance

RSS
U.S. healthcare costs continue to increase at a declining rate

U.S. healthcare costs continue to increase at a declining rate

Creekridge Capital, Healthland partner to offer financing solutions for healthcare information system

Creekridge Capital, Healthland partner to offer financing solutions for healthcare information system

iMD to expand Medical Diagnostics operations

iMD to expand Medical Diagnostics operations

Cybex first quarter net sales increase 19% to $31.0 million

Cybex first quarter net sales increase 19% to $31.0 million

Valeant issues statement to shareholders of Cephalon

Valeant issues statement to shareholders of Cephalon

Cephalon files definitive Consent Revocation Statement, recommends shareholders to reject Valeant's proposals

Cephalon files definitive Consent Revocation Statement, recommends shareholders to reject Valeant's proposals

Prism Medical first quarter revenue increases 32% to $1.8 million

Prism Medical first quarter revenue increases 32% to $1.8 million

UHT net income is $4.1 million for quarter ended March 31, 2011

UHT net income is $4.1 million for quarter ended March 31, 2011

Endologix total revenue increases 28% to $18.5 million for first quarter 2011

Endologix total revenue increases 28% to $18.5 million for first quarter 2011

Sonomax net revenue decreases to $642,766 for year ended December 31, 2010

Sonomax net revenue decreases to $642,766 for year ended December 31, 2010

MRG: Radioembolization is expected to grow from $50M in sales in 2011 to $128M in 2015

MRG: Radioembolization is expected to grow from $50M in sales in 2011 to $128M in 2015

Life Time Fitness first quarter revenue increases 9.5% to $240.6 million

Life Time Fitness first quarter revenue increases 9.5% to $240.6 million

Repligen anticipates 30% increase in total revenues for 2011

Repligen anticipates 30% increase in total revenues for 2011

Meridian Bioscience second quarter net sales increases 32% to $41.1 million

Meridian Bioscience second quarter net sales increases 32% to $41.1 million

UnitedHealth Group's consolidated first quarter 2011 revenues increased 10% year-over-year

UnitedHealth Group's consolidated first quarter 2011 revenues increased 10% year-over-year

Baxter’s first quarter global sales increase 12% to $3.3 billion

Baxter’s first quarter global sales increase 12% to $3.3 billion

Alexion first quarter non-GAAP net income increases to $56.3 million

Alexion first quarter non-GAAP net income increases to $56.3 million

Hanmi granted exclusive rights to Kinex KX01 Src kinase/pretubulin dual mechanism inhibitor for oncology indications

Hanmi granted exclusive rights to Kinex KX01 Src kinase/pretubulin dual mechanism inhibitor for oncology indications

LabCorp first quarter revenues increase 14.6% to $1,368.4 million

LabCorp first quarter revenues increase 14.6% to $1,368.4 million

Covidien second quarter net sales up 10% to $2.80 billion

Covidien second quarter net sales up 10% to $2.80 billion

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.